Abbott Slaps Teva With Suit Over Generic AndroGel
An Abbott Laboratories unit hit Teva Pharmaceuticals USA Inc. with a patent suit Friday in Delaware over Teva's bid to market its own version of AndroGel, a product at the center...To view the full article, register now.
Already a subscriber? Click here to view full article